Argan (AGX)
(Real Time Quote from BATS)
$62.09 USD
+0.45 (0.73%)
Updated Apr 23, 2024 12:54 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Argan, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 573 | 455 | 509 | 392 | 239 |
Cost Of Goods | 493 | 369 | 410 | 330 | 246 |
Gross Profit | 81 | 86 | 100 | 62 | -7 |
Selling & Adminstrative & Depr. & Amort Expenses | 44 | 45 | 55 | 39 | 49 |
Income After Depreciation & Amortization | 36 | 42 | 45 | 23 | -56 |
Non-Operating Income | 12 | 4 | 3 | 2 | 8 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 49 | 46 | 47 | 25 | -48 |
Income Taxes | 17 | 11 | 11 | 1 | -7 |
Minority Interest | 0 | 2 | -3 | 0 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 32 | 35 | 36 | 24 | -41 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 32 | 33 | 38 | 24 | -43 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 39 | 45 | 49 | 28 | -51 |
Depreciation & Amortization (Cash Flow) | 2 | 4 | 4 | 5 | 5 |
Income After Depreciation & Amortization | 36 | 42 | 45 | 23 | -56 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 13.55 | 14.18 | 15.91 | 15.83 | 15.62 |
Diluted EPS Before Non-Recurring Items | 2.39 | 2.33 | 2.90 | 1.51 | -2.60 |
Diluted Net EPS (GAAP) | 2.39 | 2.33 | 2.40 | 1.51 | -2.73 |
Fiscal Year end for Argan, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 164.55 | 163.76 | 141.35 | 103.68 | 118.78 |
Cost Of Goods | 140.92 | 144.52 | 117.61 | 89.45 | 98.75 |
Gross Profit | 23.63 | 19.24 | 23.74 | 14.22 | 20.03 |
SG&A, R&D, and Dept/Amort Expenses | 11.91 | 11.38 | 10.50 | 10.59 | 10.47 |
Income After SG&A, R&D, and Dept/Amort Expenses | 11.72 | 7.86 | 13.24 | 3.63 | 9.56 |
Non-Operating Income | 5.25 | 3.73 | 4.12 | -0.63 | 2.46 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 16.98 | 11.59 | 17.36 | 3.00 | 12.03 |
Income Taxes | 4.96 | 6.13 | 4.59 | 0.90 | -3.21 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 1.61 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 12.02 | 5.46 | 12.77 | 2.11 | 15.24 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 12.02 | 5.46 | 12.77 | 2.11 | 13.63 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 13.55 | 13.56 | 13.54 | 13.55 | 13.63 |
Diluted EPS Before Non-Recurring Items | 0.89 | 0.40 | 0.94 | 0.16 | 1.00 |
Diluted Net EPS (GAAP) | 0.89 | 0.40 | 0.94 | 0.16 | 0.97 |